Outcomes of microPulse transscleral laser therapy in eyes with prior glaucoma aqueous tube shunt.
Aqueous Tube Shunt
Cyclophotocoagulation
Glaucoma
MicroPulse Transscleral Laser
Journal
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
21
04
2022
accepted:
18
05
2023
revised:
04
05
2023
medline:
2
10
2023
pubmed:
29
5
2023
entrez:
29
5
2023
Statut:
ppublish
Résumé
To evaluate the outcomes of micropulse transscleral laser therapy (MP-TLT) in patients with uncontrolled glaucoma and prior glaucoma aqueous tube shunt. In this single‑center, retrospective, interventional case series, eyes that underwent MP-TLT and had prior glaucoma aqueous tube shunt surgeries were included. The Cyclo Glaucoma Laser System (IRIDEX Corporation, Mountain View, CA, USA) with the MicroPulse P3 probe (version 1) was used. Post‑operative data were collected at day 1, week 1, and months 1, 3, 6, 12, 18, 24, 30 and 36. A total of 84 eyes (84 patients) with mean age of 65.8 ± 15.2 years and with advanced glaucoma (baseline mean deviation -16.25 ± 6.80 dB and best-corrected visual acuity 0.82 ± 0.83 logMar) were included in the study. Baseline mean IOP was 19.95 ± 5.6 mm Hg with a mean number of medications 3.39 ± 1.02. There were statistically significant differences in IOP between baseline and all follow-up visits (p < 0.01 for all). The mean percentage of IOP reduction between baseline and different follow-up visits ranged from 23.4% to 35.5% (p < 0.01). There was a significant reduction of visual acuity (≥ 2-lines) at 1 year (30.3%) and 2 years (76.78%). There was a statistically significant reduction in the number of glaucoma medications between baseline and all follow-up visits after postoperative week 1 (p < 0.05 for all). No severe complications including persistent hypotony and related complications were observed. At the last follow-up visit, only 24 (28%) eyes out of 84 eyes remained in the study. MP-TLT is an effective treatment for reducing IOP and decreasing the number of medications in patients with advanced glaucoma and prior glaucoma aqueous tube shunt.
Identifiants
pubmed: 37247002
doi: 10.1007/s00417-023-06119-9
pii: 10.1007/s00417-023-06119-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2935-2944Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363:1711–1720. https://doi.org/10.1016/S0140-6736(04)16257-0
doi: 10.1016/S0140-6736(04)16257-0
pubmed: 15158634
Schlote T, Derse M, Rassmann K, Nicaeus T, Dietz K, Thiel HJ (2001) Efficacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma 10:294–301. https://doi.org/10.1097/00061198-200108000-00009
doi: 10.1097/00061198-200108000-00009
pubmed: 11558814
Sanchez FG, Peirano-Bonomi JC, Grippo TM (2018) Micropulse transscleral cyclophotocoagulation: a hypothesis for the ideal parameters. Med Hypothesis Discov Innov Ophthalmol 7:94–100
Sarrafpour S, Saleh D, Ayoub S, Radcliffe NM (2019) MicroPulse® transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes. Ophthalmol Glaucoma 2:167–171. https://doi.org/10.1016/j.ogla.2019.02.002
doi: 10.1016/j.ogla.2019.02.002
pubmed: 32672586
Varikuti VNV, Shah P, Rai O, Chaves AC, Miranda A, Lim BA, Dorairaj SK, Sieminski S (2019) Outcomes of micropulse® transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma 28:901–905. https://doi.org/10.1097/IJG.0000000000001339
doi: 10.1097/IJG.0000000000001339
pubmed: 31385915
Yelenskiy A, Gillette TB, Arosemena A, Stern AG, Garris WJ, Young CT, Hoyt M, Worley N, Zurakowski D, Ayyala RS (2018) Patient outcomes following micropulse® transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma 27:920–925. https://doi.org/10.1097/IJG.0000000000001023
doi: 10.1097/IJG.0000000000001023
pubmed: 29979339
Fili S, Kontopoulou K, Vastardis I, Perdikakis G, Papadonta SA, Armeni EZ, Kohlhaas M (2021) Transscleral cyclophotocoagulation with MicroPulse® laser versus Ahmed valve implantation in patients with advanced primary open-angle glaucoma. Int Ophthalmol 41:1271–1282. https://doi.org/10.1007/s10792-020-01682-0
doi: 10.1007/s10792-020-01682-0
pubmed: 33392944
Aquino MCD, Barton K, Tan AM, Sng C, Li X, Loon SC, Chew PT (2015) Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol 43:40–46. https://doi.org/10.1111/ceo.12360
doi: 10.1111/ceo.12360
pubmed: 24811050
Emanuel ME, Grover DS, Fellman RL, Godfrey DG, Smith O, Butler MR, Kornmann HL, Feuer WJ, Goyal S (2017) Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma 26:726–729. https://doi.org/10.1097/IJG.0000000000000715
doi: 10.1097/IJG.0000000000000715
pubmed: 28671927
Kuchar S, Moster MR, Reamer CB, Waisbourd M (2016) Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma. Lasers Med Sci 31:393–396. https://doi.org/10.1007/s10103-015-1856-9
doi: 10.1007/s10103-015-1856-9
pubmed: 26714976
Zaarour K, Abdelmassih Y, Arej N, Cherfan G, Tomey KF, Khoueir Z (2018) Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients. J Glaucoma 28:270–275. https://doi.org/10.1097/IJG.0000000000001174
doi: 10.1097/IJG.0000000000001174
Vig N, Ameen S, Bloom P, Crawley L, Normando E, Porteous A, Ahmed F (2020) Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma. Graefes Arch Clin Exp Ophthalmol 258:1073–1079. https://doi.org/10.1007/s00417-020-04611-0
doi: 10.1007/s00417-020-04611-0
pubmed: 32036425
Williams AL, Moster MR, Rahmatnejad K, Resende AF, Horan T, Reynolds M, Yung E, Abramowitz B, Kuchar S, Waisbourd M (2018) Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma 27:445–449. https://doi.org/10.1097/IJG.0000000000000934
doi: 10.1097/IJG.0000000000000934
pubmed: 29521718
Francis BA, Kawji AS, Vo NT, Dustin L, Chopra V (2011) Endoscopic cyclophotocoagulation (ECP) in the management of uncontrolled glaucoma with prior aqueous tube shunt. J Glaucoma 20:523–527. https://doi.org/10.1097/IJG.0b013e3181f46337
doi: 10.1097/IJG.0b013e3181f46337
pubmed: 21048513
Murakami Y, Akil H, Chahal J, Dustin L, Tan J, Chopra V, Francis B (2017) Endoscopic cyclophotocoagulation versus second glaucoma drainage device after prior aqueous tube shunt surgery. Clin Exp Ophthalmol 45:241–246. https://doi.org/10.1111/ceo.12828
doi: 10.1111/ceo.12828
pubmed: 27570215
Lim EJY, Aquino CM, Lun KWX, Lim DKA, Sng C, Loon SC, Chew PTK, Koh VTC (2021) Efficacy and Safety of Repeated Micropulse Transscleral Diode Cyclophotocoagulation in Advanced Glaucoma. J Glaucoma 30:566–574. https://doi.org/10.1097/IJG.0000000000001862
doi: 10.1097/IJG.0000000000001862
pubmed: 33927146
Ariga M, Nivean NPD, Madanagopalan VG, Mohan S (2021) Micropulse trans-scleral diode laser cyclophotocoagulation in refractory glaucoma: an initial experience in Indian eyes. Int Ophthalmol 41:2639–2645. https://doi.org/10.1007/s10792-021-01697-1
doi: 10.1007/s10792-021-01697-1
pubmed: 33550537
Tekeli O, Köse HC (2021) Comparative efficacy and safety of micropulse transscleral laser cyclophotocoagulation using different duration protocols in eyes with good visual acuity. Graefes Arch Clin Exp Ophthalmol 259:3359–3369. https://doi.org/10.1007/s00417-021-05265-2
doi: 10.1007/s00417-021-05265-2
pubmed: 34219181
Chen HS, Yeh PH, Yeh CT, Su WW, Lee YS, Chuang LH, Shen SC, Wu WC (2022) Micropulse transscleral cyclophotocoagulation in a Taiwanese population: 2-year clinical outcomes and prognostic factors. Graefes Arch Clin Exp Ophthalmol 260:1265–1273. https://doi.org/10.1007/s00417-021-05468-7
doi: 10.1007/s00417-021-05468-7
pubmed: 34694457
ELGwaily AM, Khedr SA, Assaf AH, Latif MAMAL, Elsayed HA, Latif AAMAL (2021) MicroPulse® transscleral laser therapy in the management of glaucoma patients. Arch Soc Esp Oftalmol (Engl Ed) 96:640–648. https://doi.org/10.1016/j.oftale.2020.12.005
doi: 10.1016/j.oftale.2020.12.005
pubmed: 34844684
Tan AM, Chockalingam M, Aquino MC, Lim ZI, See JL, Chew PT (2010) Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Experiment Ophthalmol 38:266–272. https://doi.org/10.1111/j.1442-9071.2010.02238.x
doi: 10.1111/j.1442-9071.2010.02238.x
pubmed: 20447122
An international consensus panel of ten glaucoma experts discusses best practices for MicroPulseTransscleral Laser Therapy. Available at: https://www.iridex.com/consensus.aspx . Accessed 25 May 2023
Dastiridou AI, Katsanos A, Denis P, Francis BA, Mikropoulos DG, Teus MA, Konstas AG (2018) Cyclodestructive procedures in glaucoma: a review of current and emerging options. Adv Ther 35:2103–2127. https://doi.org/10.1007/s12325-018-0837-3
doi: 10.1007/s12325-018-0837-3
pubmed: 30448885
pmcid: 6267695
Amoozgar B, Phan EN, Lin SC, Han Y (2017) Update on ciliary body laser procedures. Curr Opin Ophthalmol 28:181–186. https://doi.org/10.1097/ICU.0000000000000351
doi: 10.1097/ICU.0000000000000351
pubmed: 27898468
Moussa K, Feinstein M, Pekmezci M, Lee JH, Bloomer M, Oldenburg C, Sun Z, Lee RK, Ying GS, Han Y (2020) Histologic changes following continuous wave and micropulse transscleral cyclophotocoagulation: a randomized comparative study. Transl Vis Sci Technol 9:22–22. https://doi.org/10.1167/tvst.9.5.22
doi: 10.1167/tvst.9.5.22
pubmed: 32821494
pmcid: 7401863
Liu GJ, Mizukawa A, Okisaka S (1994) Mechanism of intraocular pressure decrease after contact transscleral continuous-wave Nd:YAG laser cyclophotocoagulation. Ophthalmic Res 26:65–79. https://doi.org/10.1159/000267395
Schubert HD, Agarwala A (1990) Quantitative CW Nd:YAG pars plana transscleral photocoagulation in postmortem eyes. Ophthalmic Surg 21:835–839
pubmed: 2096343
Barac R, Vuzitas M, Balta F (2018) Choroidal thickness increase after micropulse transscleral cyclophotocoagulation. Romanian J Ophthalmol 62:144–148
doi: 10.22336/rjo.2018.21
Abdelmassih Y, Tomey K, Khoueir Z (2021) Micropulse Transscleral Cyclophotocoagulation. J Curr Glaucoma Pract 15:1–7. https://doi.org/10.5005/jp-journals-10078-1298
doi: 10.5005/jp-journals-10078-1298
pubmed: 34393449
pmcid: 8322594
Foote BC, Smith JD, Allbaugh RA, Sebbag L (2021) Histologic effects of MicroPulse™ transscleral cyclophotocoagulation in normal equine eyes. Vet Ophthalmol 24:59–70. https://doi.org/10.1111/vop.12846
doi: 10.1111/vop.12846
pubmed: 33249770
Grippo TM, de Crom RMPC, Giovingo M, Töteberg-Harms M, Francis BA, Jerkins B, Brubaker JW, Radcliffe N, An J, Noecker R (2022) Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection. Clin Ophthalmol 16:1837–1846. https://doi.org/10.2147/OPTH.S365647
doi: 10.2147/OPTH.S365647
pubmed: 35698599
pmcid: 9188391